Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Denovo Biopharma

Request full access

A privately held biotech company providing a novel biomarker solution to personalize drug development

San Diego, United StatesFounded 2011Biotech & Life Sciences

About Denovo Biopharma

Denovo Biopharma is a privately held biotech company specializing in personalized medicine through innovative biomarker solutions. Operating in the pharmaceutical and biotechnology sectors, Denovo Biopharma serves biotech and pharmaceutical companies by providing a unique platform for de novo genomic biomarker discovery. This technology is particularly valuable for late-stage clinical drugs that have shown unsatisfactory efficacy in trials. By identifying biomarkers that correlate with patient responsiveness to drug candidates, Denovo Biopharma enables more targeted and cost-effective clinical trials. The company's core technology uses archived clinical samples to discover biomarkers retrospectively, which can be applied across various therapeutic areas including oncology, metabolic disorders, cardiology, immunology, and neurology. Denovo Biopharma generates revenue by partnering with biotech and pharmaceutical companies to enhance their drug development processes, thereby increasing the likelihood of successful clinical outcomes.

Source: Dealroom company data

At a glance

Status
Operational
Employees
27
Open positions
None listed
Dealroom signal
28.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing May 2024 $12M — California Institute for Regenerative Medicine ↗
SERIES DOther financing Dec 2020 $46M $415M CICC · Sangel Capital · Zhejiang Paradise Silicon Valley Asset Management Group · China Resources Pharmaceutical Group Limited —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Denovo Biopharma website traffic

Latest recorded traffic for Denovo Biopharma is 580 monthly website visits, down 42% over the last three months. Denovo Biopharma's team grew 0% over the past year.

Latest monthly visits580 3-month web change-42% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Denovo Biopharma in the San Diego ecosystem

Live from Dealroom

The Denovo Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • California Institute for Regenerative Medicine

Series B and later7 investors entered at this stage

  • CICC
  • Yingke Capital
  • Sangel Capital
  • Zhejiang Paradise Silicon Valley Asset Management Group
  • China Resources Pharmaceutical Group Limited
  • Fang Fund Partners
  • HosenCare Brothers
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States90%
🇨🇳 China10%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Denovo Biopharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Denovo Biopharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.